arrow
Z

Zhuang Kang

capital medical university
H指数:28
被引数:2,754

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Bidirectional Causal Effect Between Gut Microbiota and Glioma Risk: A Systematic Review-Based Mendelian Randomization and Immune-Mediated Effect Analysis

肠道微生物组与胶质瘤风险之间的双向因果效应:一项基于系统综述的孟德尔随机化和免疫介导效应分析

2025-12-090
OAAI
Association between decreased peripheral serum complement C3 levels and aberrant brain topology of morphological similarity networks in first-episode, drug-naïve schizophrenia

外周血清补体C3水平降低与首发、药物未使用精神分裂症患者形态学相似性网络异常脑拓扑结构之间的关联

2025-11-240
PRE
Phase 1 Study of Luvometinib Use in Pediatric Patients with Neurofibromatosis Type 1-Related Unresectable Plexiform Neurofibromas

I期Luvometinib在神经纤维瘤病1型相关不可切除性丛状神经纤维瘤患儿中的使用研究

2025-10-260
PRE
Preliminary Efficacy and Safety of Bruton Tyrosine Kinase (BTK) Inhibitor HZ-a-018 in Adult Patients with Relapsed and/or Refractory (R/R) Central Nervous System Lymphoma or Treatment-Naive (TN) Central Nervous System Lymphoma, Results from the Phase Ib Combination Part of HZ-a-018-102 Study

HZ-a-018研究(一项Bruton Tyrosine Kinase [BTK]抑制剂)在复发和/或难治性(R/R)中枢神经系统淋巴瘤或初治(TN)中枢神经系统淋巴瘤成年患者中的初步疗效与安全性:HZ-a-018-102研究Ib期联合治疗部分的结果

BLOOD
IF23.1
2024-11-050
PRE